Log in to save to my catalogue

Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-d...

Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-d...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_59a0895a37d34757859e7e9b853a7ad6

Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft

About this item

Full title

Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2021-01, Vol.11 (1), p.1563-1563, Article 1563

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

We established patient-derived xenografts (PDX) from human primary breast cancers and studied whether stability or progressive events occurred during long-term in vivo passages (up to 4 years) in severely immunodeficient mice. While most PDX showed stable biomarker expression and growth phenotype, a HER2-positive PDX (PDX-BRB4) originated a subline...

Alternative Titles

Full title

Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_59a0895a37d34757859e7e9b853a7ad6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_59a0895a37d34757859e7e9b853a7ad6

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-021-81085-y

How to access this item